Strategic partnerships Recent collaboration with Metrion Biosciences signals openness to joint demonstrations and knowledge-sharing events. Leverage co-hosted presentations to cross-sell automated patch clamp platforms and expand reach in ion channel drug discovery.

Product expansion Historically strong in automated patch clamp with SyncroPatch lines, and expansions into membrane pumps, bilayer recordings, contractility, and cell analytics. Target buyers seeking versatile, high-throughput electrophysiology solutions and integrated measurement workflows.

Launch cadence A track record of rapid product introductions (SyncroPatch 384, 384i, Dynamite 8, Port-a-Patch mini, FLEXcyte 96). Position as a continuous innovator for customers looking to upgrade capabilities and reduce screening time.

Mid-market focus Company size and revenue place Nanion in a mid-market niche with significant growth potential. Target mid-sized biotech and contract research organizations seeking scalable, high-value ion channel screening systems.

Global enablement Multiple tech stack and online presence, plus international partnerships, present opportunities to offer blended solutions (hardware, software, and services) with channel-enabled sales, localized demos, and post-sale support offerings.